
Iterum Therapeutics PLC
NASDAQ:ITRM

Iterum Therapeutics PLC?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.9099
2.91
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Iterum Therapeutics PLC hold over its rivals?
What risks and challenges
does Iterum Therapeutics PLC face in the near future?
Provide an overview of the primary business activities
of Iterum Therapeutics PLC.
Show me price targets
for Iterum Therapeutics PLC made by professional analysts.
Provide an overview of the primary business activities
of Iterum Therapeutics PLC.
What unique competitive advantages
does Iterum Therapeutics PLC hold over its rivals?
What risks and challenges
does Iterum Therapeutics PLC face in the near future?
Has there been any significant insider trading activity
in Iterum Therapeutics PLC recently?
Summarize the latest earnings call
of Iterum Therapeutics PLC.
Show all valuation multiples
for Iterum Therapeutics PLC.
Provide P/S
for Iterum Therapeutics PLC.
Provide P/E
for Iterum Therapeutics PLC.
Provide P/OCF
for Iterum Therapeutics PLC.
Provide P/FCFE
for Iterum Therapeutics PLC.
Provide P/B
for Iterum Therapeutics PLC.
Provide EV/S
for Iterum Therapeutics PLC.
Provide EV/GP
for Iterum Therapeutics PLC.
Provide EV/EBITDA
for Iterum Therapeutics PLC.
Provide EV/EBIT
for Iterum Therapeutics PLC.
Provide EV/OCF
for Iterum Therapeutics PLC.
Provide EV/FCFF
for Iterum Therapeutics PLC.
Provide EV/IC
for Iterum Therapeutics PLC.
Show me price targets
for Iterum Therapeutics PLC made by professional analysts.
What are the Revenue projections
for Iterum Therapeutics PLC?
How accurate were the past Revenue estimates
for Iterum Therapeutics PLC?
What are the Net Income projections
for Iterum Therapeutics PLC?
How accurate were the past Net Income estimates
for Iterum Therapeutics PLC?
What are the EPS projections
for Iterum Therapeutics PLC?
How accurate were the past EPS estimates
for Iterum Therapeutics PLC?
What are the EBIT projections
for Iterum Therapeutics PLC?
How accurate were the past EBIT estimates
for Iterum Therapeutics PLC?
Compare the revenue forecasts
for Iterum Therapeutics PLC with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Iterum Therapeutics PLC and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Iterum Therapeutics PLC against its competitors.
Analyze the profit margins
(gross, operating, and net) of Iterum Therapeutics PLC compared to its peers.
Compare the P/E ratios
of Iterum Therapeutics PLC against its peers.
Discuss the investment returns and shareholder value creation
comparing Iterum Therapeutics PLC with its peers.
Analyze the financial leverage
of Iterum Therapeutics PLC compared to its main competitors.
Show all profitability ratios
for Iterum Therapeutics PLC.
Provide ROE
for Iterum Therapeutics PLC.
Provide ROA
for Iterum Therapeutics PLC.
Provide ROIC
for Iterum Therapeutics PLC.
Provide ROCE
for Iterum Therapeutics PLC.
Provide Gross Margin
for Iterum Therapeutics PLC.
Provide Operating Margin
for Iterum Therapeutics PLC.
Provide Net Margin
for Iterum Therapeutics PLC.
Provide FCF Margin
for Iterum Therapeutics PLC.
Show all solvency ratios
for Iterum Therapeutics PLC.
Provide D/E Ratio
for Iterum Therapeutics PLC.
Provide D/A Ratio
for Iterum Therapeutics PLC.
Provide Interest Coverage Ratio
for Iterum Therapeutics PLC.
Provide Altman Z-Score Ratio
for Iterum Therapeutics PLC.
Provide Quick Ratio
for Iterum Therapeutics PLC.
Provide Current Ratio
for Iterum Therapeutics PLC.
Provide Cash Ratio
for Iterum Therapeutics PLC.
What is the historical Revenue growth
over the last 5 years for Iterum Therapeutics PLC?
What is the historical Net Income growth
over the last 5 years for Iterum Therapeutics PLC?
What is the current Free Cash Flow
of Iterum Therapeutics PLC?
Discuss the annual earnings per share (EPS)
trend over the past five years for Iterum Therapeutics PLC.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
IE |
![]() |
Iterum Therapeutics PLC
NASDAQ:ITRM
|
37.8m USD | -3.7 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
729.1B USD | 35.3 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
364B USD | 12.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 13.2 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
207.2B CHF | 9.4 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
186.3B CHF | 10.5 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
161.6B GBP | 131.8 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
201.7B USD | 8.6 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 261.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
136.6B USD | 7.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
IE |
![]() |
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Average EV/EBITDA:
433.6
|
N/A | N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
35.3
|
30%
|
1.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
12.2
|
7%
|
1.7 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
13.2
|
13%
|
1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.4
|
5%
|
1.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
10.5
|
5%
|
2.1 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
131.8
|
10%
|
13.2 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
8.6
|
8%
|
1.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
261.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.5
|
2%
|
3.7 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.